Soley Therapeutics is a San Francisco-based, privately-held biotechnology company that is combining artificial intelligence with unique proprietary molecular and cellular response detection for discovering and developing new efficacious drugs, using image acquisition-based approaches. We have translated decades of research by Soley’s co-founders on cell-responses to perturbations and resulting information-flow within the cell, into quantifiable high-resolution imaging to identify and accelerate the development of novel therapeutic molecules for complex diseases. Mission To develop safe and effective new drugs for treatment of a broad spectrum of diseases for which there are currently limited treatment options, using our disruptive, high-throughput drug development technology and Artificial Intelligence/Machine Learning/Deep Learning (AL/ML/DL) which together are transformative in the drug development industry. Values